Pharmacokinetic and tolerability profiles of tobramycin nebuliser solution 300 mg/4 ml administered by PARI eFlow((R)) rapid and PARI LC Plus((R)) nebulisers in cystic fibrosis patients - Govoni, M; Poli, G; Acerbi, D (Pulmonary pharmacology & therapeutics, 2013)
et al.